The application window for changes in the Swiss Classification of Surgical Operations (CHOP) will open on June 1, 2026. Interested parties can submit applications until September 14, 2026. The announcement of the 2026 CHOP application period resumes the application process, which was cancelled for the year 2025.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Santos et al. systematically reviewed and mapped 26 frameworks for the economic evaluation of digital health technologies (DHTs) to identify methodological inconsistencies and inform more robust standards.

A new version of the Nomenclature of Medical Biology Procedures (NABM 102), effective from March 3, 2026, was published in France. Changes include the introduction of one new code and the deletion and modification of several codes.

In Germany, digital health applications (DiGAs) that can be prescribed by physicians and psychotherapists and reimbursed by statutory health insurers are listed in the Directory of Digital Health Applications maintained by the Federal Institute for Drugs and Medical Devices (BfArM). As of February 23, 2026, a total of 61 apps are available in the Directory and thus eligible for reimbursement.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its EU HTA Publications Digest. In a recent publication, Dang et al. reviewed the implementation of Joint Clinical Assessments under the EU HTAR (Regulation 2021/2282), analyzing methodological, regulatory, and stakeholder implications across EU Member States.

In January 2026, the HTA body of Tuscany Regional Healthcare published two rapid HTA reports (one new assessment and one reassessment) on medical devices in the cardiovascular and surgical fields.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of February 23rd, we plan to work on 16 projects. Review the complete list of planned activities in this post.

On January 30, 2026, the Federal Ministry of Labor, Social Affairs, Health, Care and Consumer Protection (BMASGPK) and Gesundheit Österreich GmbH (GÖG) jointly presented the National Cancer Framework Program 2026-2035. It serves as a strategic compass, setting the direction for cancer control and care in Austria over the next ten years, although it is not legally binding. The Program comprises four areas of action, 22 objectives, and 113 measures.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Dinnes et al. conducted a methodological review of 45 HTAs (50 review questions) of diagnostic tests to assess how clearly clinical pathways, test claims, and outcomes are specified within existing HTAs.

In February 2026, the Royal Decree was issued, regulating the selective financing procedure for certain health products – specifically, some types of medical aids – covered under the pharmaceutical benefit of the National Health System for non-hospitalized patients, and establishing the margins for their distribution and dispensing. The new regulation will update the old framework in place since 1996, establishing a clear, transparent, and structured system for selective financing and price-setting, with uniform criteria for the inclusion, modification, and exclusion of health products. The regulation will enter into force on July 1, 2026.

On February 7, 2026, the Ministry of Health, Family, Autonomy and People with Disability released an update of the 2014 regulations on conditions of performing IVD tests outside the medical biology laboratory. The new regulation expands the list of locations eligible for point-of-care testing (POCT) and provides an explicit list of tests that can be performed as POCT, and links them to eligible locations. It also introduces a quality assurance framework, accreditation requirements, and mandates that comprehensive conventions be concluded between the remote sites providing POCT and the responsible laboratories.

On January 30, 2026, the Institute for the Hospital Remuneration System (InEK) published the list of innovation funding (NUB) requests submitted by hospitals in 2025. The medical technologies of cardiovascular, endoscopy, extracorporeal, gastrointestinal, neuromodulation, peripheral vascular, and other technology groups obtained a positive status 1.